Anthem Biosciences P/B Ratio
Anthem Biosciences (ANTHEM) P/B ratio is 12.92 (High), book value per share ₹215.18 vs Healthcare average P/B of -0.35 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see ANTHEM share price.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
ANTHEM P/B Ratio — Valuation Insights & Book Value Analysis
Anthem Biosciences price-to-book ratio interpretation, valuation status and historical context — current P/B 12.92 (High). Compare with ANTHEM fair value estimate to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 12.92, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 326.4% above historical average
- Trading at premium to sector average PB of -0.35
Anthem Biosciences P/B Ratio Historical Trend
ANTHEM annual price-to-book ratio — 1 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View ANTHEM 52-week chart for the annual high/low range and current price position.
ANTHEM Historical P/B Ratio — Book Value Per Share & Year-End Price
Anthem Biosciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 3.03 | ₹215.18 | ₹651.50 | ₹2,410 | High |
ANTHEM vs Healthcare Peers — P/B Ratio Comparison
Anthem Biosciences P/B 12.92 vs Healthcare average -0.35, median 0.61 — range -18.41–1.04.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Parmax Pharma | PARMAX | -3.24 | ₹23 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.6 | ₹53 | Low |